44 employees
ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.
2009
$26M
from 3 investors over 3 rounds
Ethris raised $26M on February 1, 2022
Investors: Laureus Capital
Ethris raised undisclosed on December 13, 2011
Investors: HS Lifescience and OrbiMed Advisors